日报更新时间：
周报更新时间：04-11 03:39
今开价：99.84
最高价：100.91
成交量：46197.0
昨收价：99.89
最低价：99.02
最新价：100.63
中文名称：优莎娜
英文名称：Usana Health Sciences
行业：医疗
简介：Usana Health Sciences, Inc.于1992年由Myron W. Wentz成立
电话：1-801-9547100
USANA Health Sciences是维生素及营养补充品销售公司，产品包括个人保健、营养产品、美容及体重控制产品，透过网路及直销模式销售，是全球第20大多层次直销公司，截止2013年12月31日，优莎娜在全球拥有265,000活跃推广员和78000名活跃客户。2012年，公司收入的91%都来自联营公司，截止2013年底，USANA 公司的产品已远销美国，加拿大，澳大利亚，新西兰，英国，荷兰，日本，香港，台湾，韩国，新加坡，墨西哥，马来西亚，菲律宾，法国，哥伦比亚和泰国。优莎娜健康科学公司制造和销售基于科学的营养品和个人护理产品，旨在减少世界各地的慢性退行性疾病的风险。优莎娜USANA Health Sciences提供的产品包括： USANA Nutritionals Essentials产品线，包括：适合各年龄组使用的维生素和矿物质补充剂； 针对心血管、骨骼/结构、消化系统等健康需求的营养补充剂； 食品，包括：低血糖的代餐奶昔、零食吧及相关产品，提供宏观营养； Sensébeautiful个人护理产品，如：护肤品、头发护理产品等； 孕妇营养品、婴儿及儿童营养品&护理产品。优莎娜USANA Health Sciences大事记： 2007年8月，USANA公司因财务审计原因一度收购SEC的纳斯达克退市警告； 2007年10月，NASDAQ 决定USANA符合财务审计要求，决定继续保留其上市公司资格； 2011年1月3日，优莎娜由纳斯达克NASDAQ转板纽交所NYSE交易，股票代码：USNA。
| 交易日期 | 交易人 | 职位 | 类型 | 交易份额 | 价格 |
|---|---|---|---|---|---|
| 2019-07-25 | Fuller (Gilbert A) | Director | Sell | 329 | 66.60 |
| 2019-07-22 | Foukas (Joshua) | Officer | Sell | 179 | 63.05 |
| 2019-07-22 | Foukas (Joshua) | Officer | Buy | 432 | -- |
| 2019-06-29 | Pelosi (Peggie) | Director | Buy | 329 | -- |
| 2019-06-29 | Fuller (Gilbert A) | Director | Buy | 329 | -- |
| 2019-06-29 | Auciaux (Robert) | Director | Sell | 99 | 79.43 |
| 2019-06-29 | Pelosi (Peggie) | Director | Sell | 148 | 79.43 |
| 2019-06-29 | Peng (Feng) | Director | Buy | 329 | -- |
| 2019-06-29 | Winssinger (Frederic J.) | Director | Buy | 329 | -- |
| 2019-06-29 | Auciaux (Robert) | Director | Buy | 329 | -- |
| 2019-05-05 | Fuller (Gilbert A) | Director | Sell | 282 | 86.58 |
| 2019-04-30 | Iiekking (G Douglas) | Chief Financial Officer | Buy | 886 | -- |
| 2019-04-30 | Iiekking (G Douglas) | Chief Financial Officer | Sell | 376 | 91.34 |
| 2019-03-30 | Pelosi (Peggie) | Director | Buy | 233 | -- |
| 2019-03-30 | Winssinger (Frederic J.) | Director | Buy | 282 | -- |
| 2019-03-30 | Nixon (J Scott) | Director | Buy | 282 | -- |
| 2019-03-30 | Fuller (Gilbert A) | Director | Buy | 282 | -- |
| 2019-03-30 | Auciaux (Robert) | Director | Buy | 282 | -- |
| 2019-03-30 | Pelosi (Peggie) | Director | Sell | 108 | 83.87 |
| 2019-03-30 | Peng (Feng) | Director | Buy | 282 | -- |
| 2019-03-30 | Auciaux (Robert) | Director | Sell | 85 | 83.87 |
| 2019-02-10 | Fuller (Gilbert A) | Director | Sell | 282 | 110.20 |
| 2019-02-06 | Winssinger (Frederic J.) | Director | Sell | 282 | 105.91 |
| 2019-02-05 | Brown (Jim H) | President | Buy | 1373 | -- |
| 2019-02-05 | Mulham (David Mulham) | Officer | Buy | 873 | -- |
| 机构持股 | |||||
|---|---|---|---|---|---|
| 持有者 | 持有份额 | 持股比例 | 份额变化 | 变化率 | 报告日期 |
| Geode Capital Management, LLC | 217920 | 0.93% | -180122 | -45.25% | 2019-03-31 |
| Vanguard Investments Australia Ltd | 420580 | 1.83% | 1425 | 0.34% | 2019-07-31 |
| Dimensional Fund Advisors LP | 498568 | 2.17% | -9997 | -1.97% | 2019-07-31 |
| Dimensional Fund Advisors, Inc. | 617677 | 2.65% | -9872 | -1.57% | 2019-03-31 |
| Acadian Asset Management LLC | 832600 | 3.57% | 687597 | 474.20% | 2019-03-31 |
| BlackRock Inc | 1334272 | 5.72% | 244625 | 22.45% | 2019-03-31 |
| Vanguard Group Inc | 1464217 | 6.27% | 112761 | 8.34% | 2019-03-31 |
| BlackRock Fund Advisors | 1462053 | 6.36% | 2678 | 0.18% | 2019-07-31 |
| Renaissance Technologies Corp | 1907366 | 8.17% | 25692 | 1.37% | 2019-03-31 |
| ARONSON+JOHNSON+ORTIZ | 396850 | 1.70% | -16874 | -4.08% | 2019-03-31 |
| Old Mutual Asset Managers UK Ltd | 363410 | 1.56% | 127543 | 54.07% | 2019-03-31 |
| Arrowstreet Capital Limited Partnership | 317355 | 1.36% | -10101 | -3.08% | 2019-03-31 |
| Man Group Ltd | 220078 | 0.94% | 143083 | 185.83% | 2019-03-31 |
| D. E. Shaw & Co LP | 240047 | 1.03% | 126466 | 111.34% | 2019-03-31 |
| Millennium Management LLC | 244610 | 1.05% | 130657 | 114.66% | 2019-03-31 |
| Robeco Institutional Asset Mgmt BV | 246416 | 1.06% | 8205 | 3.44% | 2019-03-31 |
| Northern Trust Investments Inc | 261249 | 1.14% | 3068 | 1.19% | 2019-07-31 |
| State Street Corporation | 270421 | 1.16% | 5793 | 2.19% | 2019-03-31 |
| AQR Capital Management LLC | 282474 | 1.21% | 9679 | 3.55% | 2019-03-31 |
| Morgan Stanley - Brokerage Accounts | 296481 | 1.27% | 270241 | 1029.88% | 2019-03-31 |
| BlackRock Asset Management Canada Ltd | 289794 | 1.24% | -128 | -0.04% | 2019-05-31 |
| Apg All Pensions Group | 259800 | 1.11% | 159700 | 159.54% | 2018-12-31 |
| APG Asset Management | 259800 | 1.11% | 159700 | 159.54% | 2018-12-31 |
| Prudential Financial Inc | 249833 | 1.07% | -37249 | -12.98% | 2018-12-31 |
| Teachers Advisors LLC | 215802 | 0.93% | -215438 | -49.96% | 2018-12-31 |
| Quantitative Management Associates LLC | 225531 | 0.97% | -35515 | -13.60% | 2018-12-31 |
| TIAA-CREF Investment Management LLC | 205295 | 0.88% | -180057 | -46.73% | 2018-12-31 |
| Northern Trust Investments N A | 192929 | 0.80% | 8730 | 4.74% | 2018-09-30 |
| Northern Trust Corp | 192929 | 0.80% | 8730 | 4.74% | 2018-09-30 |
| Deutsche Bank AG | 246002 | 1.03% | 44038 | 21.80% | 2018-09-30 |
| Myron W. Wentz | 10579899 | 44.13% | -445854 | -4.04% | 2018-05-29 |
| Nordea Investment Mgmt Bank Demark A/s | 248263 | 1.04% | -106338 | -29.99% | 2018-06-30 |
| BlackRock Institutional Trust Company NA | 384862 | 1.61% | 30997 | 8.76% | 2018-06-30 |
| Goldman Sachs Group Inc | 193005 | 0.80% | 85981 | 80.34% | 2018-06-30 |
| Fidelity Management & Research Company | 1000166 | 4.17% | -28566 | -2.78% | 2018-11-30 |
| Fidelity Management and Research Company | 239443 | 1.00% | -737802 | -75.50% | 2018-06-30 |
| FMR Inc | 239443 | 0.99% | -737802 | -75.50% | 2018-06-30 |
| Renaissance Technologies LLC | 1930966 | 8.05% | 1930966 | -- | 2017-12-29 |
| Schroder Investment Management Group | 277388 | 1.15% | -55670 | -16.71% | 2018-06-30 |
| State Street Corp | 253566 | 1.05% | 24491 | 10.69% | 2018-06-30 |
| Nordea Inv Management AB, Copenhagen | 238843 | 0.99% | -17826 | -6.95% | 2018-07-31 |
| Teachers Advisors Inc | 210426 | 0.87% | 3188 | 1.54% | 2018-06-30 |
| DZ BANK AG Deutsche Zentral-Genossenschaftsbank | 164075 | 0.68% | -71329 | -30.30% | 2018-06-30 |
| Matarin Capital Management LLC | 139442 | 0.58% | -17442 | -11.12% | 2018-06-30 |
| Charles Schwab Investment Management Inc | 127919 | 0.53% | -272 | -0.21% | 2018-06-30 |
| Hood River Capital Management LLC | 152686 | 0.63% | 152686 | -- | 2018-03-31 |
| NORGES BANK | 372014 | 1.55% | 175246 | 89.06% | 2017-12-31 |
| Fidelity Institutional Asset Management | 138133 | 0.58% | -21252 | -13.33% | 2017-12-31 |
| UBS Securities LLC | 140270 | 0.58% | -3014 | -2.10% | 2017-12-31 |
| Schroder Investment Management Ltd | 169769 | 0.71% | 140 | 0.08% | 2017-11-30 |
| Old Mutual Global Investors (UK) Limited | 159047 | 0.65% | 63341 | 66.18% | 2017-06-30 |
| Phocas Financial Corp | 122736 | 0.51% | -5207 | -4.07% | 2017-12-31 |
| Numeric Investors LLC | 107900 | 0.45% | 90800 | 530.99% | 2017-12-31 |
| Two Sigma Investments LLC | 104778 | 0.44% | 15013 | 16.72% | 2017-09-30 |
| Morgan Stanley & Co Inc | 135280 | 0.55% | -210520 | -60.88% | 2017-06-30 |
| Mellon Capital Management Corporation | 66581 | 0.55% | -482 | -0.72% | 2016-09-30 |
| Renaissance TechnologiesLLC | 797883 | 3.00% | 80586183 | 0.10% | 1999-11-30 |
| FMRLLC | 1146907 | 3.00% | 115837607 | 0.10% | 1999-11-30 |
| Myron W. Wentz, Ph.D. | 6498110 | 3.00% | 656309110 | 0.50% | 1999-11-30 |
| 共同基金持股 | |||||
|---|---|---|---|---|---|
| 持有者 | 持有份额 | 持股比例 | 份额变化 | 变化率 | 报告日期 |
| DFA US Core Equity 1 Portfolio | 60574 | 0.26% | -- | -- | 2019-05-31 |
| TIAA-CREF Quant Small-Cap Equity Fund | 162560 | 0.71% | -- | -- | 2019-06-30 |
| Vanguard Extended Market Index Fund | 178487 | 0.78% | -12310 | -6.45% | 2019-06-30 |
| Vanguard Small Cap Growth Index Fund | 205438 | 0.89% | -7582 | -3.56% | 2019-06-30 |
| DFA US Small Cap Portfolio | 206727 | 0.90% | -- | -- | 2019-05-31 |
| iShares Russell 2000 ETF | 294866 | 1.28% | 572 | 0.19% | 2019-07-30 |
| Vanguard Small Cap Index | 356090 | 1.55% | -19702 | -5.24% | 2019-06-30 |
| Vanguard Total Stock Market Index Fund | 416698 | 1.81% | 40 | 0.01% | 2019-06-30 |
| iShares Core S&P Small-Cap ETF | 805481 | 3.51% | 770 | 0.10% | 2019-07-30 |
| iShares S&P Small-Cap 600 Growth ETF | 146970 | 0.64% | -- | -- | 2019-07-30 |
| iShares Russell 2000 Growth ETF | 124094 | 0.54% | 1525 | 1.24% | 2019-07-30 |
| Wasatch Micro Cap Fund | 95806 | 0.42% | 53628 | 127.15% | 2019-06-30 |
| OMIM GBP Merian Global Equity | 61606 | 0.27% | 2332 | 3.93% | 2018-12-31 |
| Vanguard Market Neutral Fund | 62818 | 0.27% | -- | -- | 2019-03-31 |
| Fidelity | 62891 | 0.27% | -2100 | -3.23% | 2019-06-30 |
| Federated MDT Small Cap Growth Fund | 65009 | 0.28% | 10417 | 19.08% | 2019-06-30 |
| AQR Small Cap Multi-Style Fund | 69069 | 0.30% | -14915 | -17.76% | 2019-06-30 |
| Vanguard Consumer Staples Fund | 74272 | 0.32% | 78 | 0.11% | 2019-06-30 |
| JNL/RAFI Multi-Factor US Equity Fund | 75186 | 0.33% | 75186 | -- | 2019-03-31 |
| DFA US Core Equity II Fund | 93475 | 0.41% | -- | -- | 2019-05-31 |
| State Street Russell Small/Mid Cap | 54147 | 0.23% | -- | -- | 2019-06-30 |
| NT R2000 Growth Index Fund - Non-Lending | 55180 | 0.24% | 638 | 1.17% | 2019-03-31 |
| Old Mutual Global Equity | 64521 | 0.28% | 64521 | -- | 2019-03-31 |
| DFA Tax Managed US Small Cap Portfolio | 53904 | 0.23% | -- | -- | 2019-04-30 |
| JNL/RAFI Fundamental US Small Cap Fd | 75186 | 0.32% | 75186 | -- | 2019-03-31 |
| iShares US Small Cap ETF (CAD-Hedged) | 259741 | 1.11% | -432 | -0.17% | 2019-05-30 |
| JNL/Mellon Capital JNL 5 Fund | 75186 | 0.32% | 75186 | -- | 2019-03-31 |
| Vanguard Small Cap Index Fund | 376832 | 1.61% | 3756 | 1.01% | 2019-04-30 |
| Robeco QI Global Multi-Factor Eqs Fd | 62115 | 0.27% | -- | -- | 2019-03-31 |
| CREF Stock Account | 75880 | 0.33% | -60462 | -44.35% | 2019-02-28 |
| CREF Global Equities Account | 60965 | 0.26% | -- | -- | 2019-02-28 |
| Merian Global Equity Fund | 59274 | 0.25% | -3825 | -6.06% | 2018-06-30 |
| Acadian Global Managed Vol Eq UCITS | 51419 | 0.22% | -- | -- | 2019-01-31 |
| SEI Global Managed Volatility (SIMT) Fd | 44468 | 0.19% | -- | -- | 2019-01-31 |
| Federated MDT Small Cap Core Fund | 43746 | 0.19% | 2505 | 6.07% | 2018-12-31 |
| Robeco QI Instl Glb Dev Momentum Eqs | 43533 | 0.18% | -- | -- | 2018-12-31 |
| AST Prudential Growth Allocation Port | 45700 | 0.19% | -10500 | -18.68% | 2018-11-30 |
| DFA US Micro Cap Portfolio | 82513 | 0.34% | -6462 | -7.26% | 2018-10-31 |
| Fidelity Global Intrinsic Value CN Class | 44986 | 0.19% | -3768 | -7.73% | 2018-06-30 |
| Fidelity NorthStar Balanced | 112500 | 0.46% | -17848 | -13.69% | 2017-12-31 |
| Vanguard Total Stock Mkt Idx | 303639 | 1.25% | 5016 | 1.68% | 2018-07-31 |
| DFA US Small Cap I | 193202 | 0.80% | -- | -- | 2018-07-31 |
| Vanguard Small Cap Growth Index Inv | 173751 | 0.72% | 2660 | 1.55% | 2018-07-31 |
| TIAA-CREF Small-Cap Equity Instl | 168560 | 0.70% | -- | -- | 2018-07-31 |
| Vanguard Extended Market Idx Inv | 150295 | 0.62% | 700 | 0.47% | 2018-07-31 |
| CREF Stock R1 | 123908 | 0.51% | 978 | 0.80% | 2018-07-31 |
| iShares Russell 2000 Growth | 122312 | 0.50% | -118 | -0.10% | 2018-09-12 |
| DFA US Micro Cap I | 106902 | 0.44% | -100 | -0.09% | 2018-07-31 |
| Vanguard Consumer Staples ETF | 62254 | 0.26% | 1420 | 2.33% | 2018-07-31 |
| DFA US Core Equity 2 I | 93475 | 0.39% | -- | -- | 2018-07-31 |
| CREF Global Equities R1 | 60965 | 0.25% | -- | -- | 2018-07-31 |
| DFA US Core Equity 1 I | 60574 | 0.25% | -- | -- | 2018-07-31 |
| AQR Small Cap Multi-Style N | 67149 | 0.28% | 13300 | 24.70% | 2018-06-30 |
| DFA Tax-Managed US Small Cap | 53904 | 0.22% | -- | -- | 2018-07-31 |
| Fidelity Spartan | 52999 | 0.22% | 2371 | 4.68% | 2018-07-31 |
| SEI Global Managed Volatility A (SIMT) | 44468 | 0.18% | -- | -- | 2018-08-31 |
| Federated MDT Small Cap Core A | 41241 | 0.17% | 41241 | -- | 2018-06-30 |
| Schwab US Small-Cap ETF | 30589 | 0.15% | -- | -- | 2018-07-26 |
| DFA T.A. US Core Equity 2 I | 33692 | 0.14% | -- | -- | 2018-05-31 |
| Bernstein Small Cap Core Z | 33460 | 0.14% | -13130 | -28.18% | 2018-05-31 |
| Hartford Small Cap Growth A | 28702 | 0.12% | -- | -- | 2018-04-30 |
| Federated MDT Small Cap Growth A | 2561796 | 0.12% | 2530201 | 8008.23% | 2018-03-31 |
| Schwab Small-Cap Equity | 27958 | 0.12% | 27958 | -- | 2018-03-31 |
| State Street Russell Small/Mid Cap Idx Fd Cl I | 34860 | 0.14% | 2078 | 6.34% | 2017-06-30 |
| Columbia VP US Equities 2 | 27770 | 0.12% | -- | -- | 2017-12-31 |
| Northern Trust Russell 2000 Index Fund - DC - Non-Lending | 27360 | 0.11% | -555 | -1.99% | 2017-12-31 |
| JNL/Mellon Capital JNL 5 B | 55880 | 0.46% | -838 | -1.48% | 2016-09-30 |
| Vanguard Strategic Equity Inv | 42947 | 0.36% | -37300 | -46.48% | 2016-09-30 |
| William Blair Small Cap Growth I | 56520 | 0.23% | -- | -- | 2016-12-31 |
| Fidelity® Ser Intrinsic Opportunities Fd | 500000 | 3.90% | -- | -- | 2015-07-31 |
| DFA U.S. Micro Cap Portfolio | 135744 | 1.10% | -- | -- | 2015-09-30 |
| Vanguard Strategic Equity Fund | 131000 | 1.00% | 16600 | 14.50% | 2015-09-30 |
| iShares Russell 2000 (AU) | 89619 | 0.70% | -114 | -0.10% | 2015-11-19 |
| DFA U.S. Small Cap Portfolio | 67611 | 0.50% | -- | -- | 2015-09-30 |
| PowerShares DWA Cnsmr Staples Mom Port | 53657 | 0.40% | -- | -- | 2015-11-19 |
| Columbia VP US Equities Fund | 45710 | 0.40% | -- | -- | 2015-09-30 |
| JPMorgan US Small Company Fund | 44700 | 0.40% | 1500 | 3.50% | 2015-09-30 |
| Fidelity Northstar Currency Neutral Cl | 500000 | 3.90% | -- | -- | 2015-06-30 |
| Robert Anciaux | Robert Anciaux is on the board of USANA Health Sciences, Inc. and MedApps, Inc. and Managing Director at S.E.I. s.a. Mr. Anciaux received an undergraduate degree from Universit�0�1�0�8 Libre de Bruxelles and a graduate degree from the University of Phoenix. |
|---|---|
| Robert Andrew Sinnott | Currently, Robert Andrew Sinnott holds the position of Chief Scientific Officer for USANA Health Sciences, Inc. Dr. Sinnott previously was Chief Executive & Scientific Officer at Mannatech, Inc., Director & Vice President at Larrea Biosciences Corp. and Research Director at Gaiaventures Ltd. He received an undergraduate degree, a doctorate and a graduate degree from Arizona State University. |
| Kevin G. Guest | Founder of FMG Productions, Inc., Kevin G. Guest is on the board of Direct Selling Association and Chief Executive Officer & Director at USANA Health Sciences, Inc. Mr. Guest previously was Managing Partner at FMG Productions, Inc. Mr. Guest received an undergraduate degree from Brigham Young University. |
| Myron W. Wentz | Founder of USANA Health Sciences, Inc., Sanoviv SA de CV and Gull Laboratories, Inc., Myron W. Wentz is an entrepreneur who holds the position of Chairman at USANA Health Sciences, Inc. Dr. Wentz previously was Chairman of Gull Laboratories, Inc. He received a graduate degree from the University of North Dakota, a doctorate from the University of Utah and an undergraduate degree from North Central College. |
| Gilbert A. Fuller | Gilbert A. Fuller is on the board of Security National Financial Corp. and USANA Health Sciences, Inc. He previously was Treasurer & Chief Administrative Officer at Melaleuca, Inc., Executive Vice President of Dolphin Winder LLC and Treasurer & Vice President for Saint-Gobain Abrasives, Inc. Mr. Fuller received an undergraduate degree and an MBA from the University of Utah. |
| Daniel A. Macuga | Presently, Daniel A. Macuga is Chief Communications & Marketing Officer at USANA Health Sciences, Inc. Mr. Macuga received an undergraduate degree from the University of California San Diego. |
| D. Richard Williams | Mr. Kevin G. Guest is a Chief Executive Officer & Director at USANA Health Sciences, Inc. He is on the Board of Directors at Direct Selling Association and USANA Health Sciences, Inc. Mr. Guest was previously employed as a Managing Partner by FMG Productions, Inc. He received his undergraduate degree from Brigham Young University. |
| G. Douglas Hekking | Presently, G. Douglas Hekking occupies the position of Chief Financial Officer at USANA Health Sciences, Inc. He received an undergraduate degree from the University of Utah and an MBA from Brigham Young University. |
| Frederic J. Winssinger | Frederic J. Winssinger founded PlanningCore Wealth Advisors LLC. He is on the board of USANA Health Sciences, Inc. and Managing Partner at RW Partners LLC. In the past Mr. Winssinger held the position of Portfolio Manager at Banco JPMorgan SA and Portfolio Manager at CapitalatWork SA. Mr. Winssinger received an undergraduate degree from Claremont McKenna College and an MBA from The Wharton School of the University of Pennsylvania. |
| Robert Andrew Sinnott | Currently, Robert Andrew Sinnott holds the position of Chief Scientific Officer for USANA Health Sciences, Inc. Dr. Sinnott previously was Chief Executive & Scientific Officer at Mannatech, Inc., Director & Vice President at Larrea Biosciences Corp. and Research Director at Gaiaventures Ltd. He received an undergraduate degree, a doctorate and a graduate degree from Arizona State University. |
| Robert Anciaux | Robert Anciaux is on the board of USANA Health Sciences, Inc. and MedApps, Inc. and Managing Director at S.E.I. s.a. Mr. Anciaux received an undergraduate degree from Universit�0�1�0�8 Libre de Bruxelles and a graduate degree from the University of Phoenix. |
| Patrique Richards | Presently, Patrique Richards is Director-Investor Relations of USANA Health Sciences, Inc. |
| G. Douglas Hekking | Presently, G. Douglas Hekking occupies the position of Chief Financial Officer at USANA Health Sciences, Inc. He received an undergraduate degree from the University of Utah and an MBA from Brigham Young University. |
| Jim Brown | Jim Brown is President & Chief Operating Officer of USANA Health Sciences, Inc. In the past Mr. Brown was Plant Manager at SPC Resources, Inc. Mr. Brown received an undergraduate degree and an MBA from Francis Marion University. |
| Kevin G. Guest | Founder of FMG Productions, Inc., Kevin G. Guest is on the board of Direct Selling Association and Chief Executive Officer & Director at USANA Health Sciences, Inc. Mr. Guest previously was Managing Partner at FMG Productions, Inc. Mr. Guest received an undergraduate degree from Brigham Young University. |
| Paul A. Jones | Paul A. Jones is Chief Leadership Development Officer at USANA Health Sciences, Inc. In the past he held the position of Vice President-Operations for Associated Food Stores, Inc. He received a graduate degree from the University of Phoenix and an undergraduate degree from Utah State University. |
| Feng Peng | Feng Peng is on the board of USANA Health Sciences, Inc. and Portfolio Manager & Partner at Linden Rose Investment LLC. In the past Mr. Peng occupied the position of Chief Financial Officer for Ossen Innovation Co., Ltd. and Senior Vice President at MZ Group. He received an undergraduate degree from Shanghai Jiao Tong University and a graduate degree from New Jersey Institute of Technology. |
| Walter Noot | Currently, Walter Noot occupies the position of Chief Information Officer at USANA Health Sciences, Inc. In his past career Mr. Noot held the position of Chief Information Officer & Senior VP-Operations at Young Living Essential Oils LC and Chief Operating Officer for MonaVie LLC. He received an undergraduate degree from Brigham Young University. |
| David Mulham | David Mulham is Chief Sales Officer for USANA Health Sciences, Inc. |
| Brent Neidig | Brent Neidig is Managing Director-China Region at USANA Health Sciences, Inc. Mr. Neidig received an MBA from David Eccles School of Business. |
| Joshua Foukas | Currently, Joshua Foukas is Secretary & Chief Legal Officer of USANA Health Sciences, Inc. He received an undergraduate degree from the University of Utah and a graduate degree from the University of Idaho. |
| J. Scott Nixon | J. Scott Nixon is on the board of USANA Health Sciences, Inc., Utah State University and Deseret Trust Co. and Director-Utah Chapter at National Association of Corporate Directors. He previously occupied the position of Partner at PricewaterhouseCoopers LLP. Mr. Nixon received an undergraduate degree and a graduate degree from Utah State University. |
| Kevin Mcmurray | Kevin Mcmurray occupies the position of General Counsel at LifeVantage Corp. Mr. Mcmurray is also Assistant General Counsel at USANA Health Sciences, Inc. In his past career Mr. Mcmurray was Associate General Counsel at Unicity International, Inc., Compliance Officer at USANA Health Sciences, Inc., Assistant General Counsel at Shaklee Corp. and Assistant General Counsel at Metabolife International, Inc. He received a graduate degree from Creighton University and a graduate degree from the University of the Pacific. |
| Peggie Pelosi | Peggie Pelosi is on the board of USANA Health Sciences, Inc. and Innovator's Alliance Corp. and Founding Partner of Orenda Connections. |
abu_quant
扫一扫关注阿布量化
热门推荐
全部评论 0
暂无评论